Tabuco, Dereck E.

HRN: 02-16-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2026
CEFTRIAXONE 1G (VIAL)
04/24/2026
05/01/2026
IVTT
2g
OD
CAP-MR, UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: